ClinicalTrials.gov
public full text
Public Domain
Clinical Performance of the MaterniT21 PLUS LDT in Multiple Gestation Pregnancies
This study will evaluate the clinical performance of massively parallel sequencing (MPS) using the MaterniT21 PLUS LDT in the detection of fetal aneuploidy in circulating cfDNA extracted from a maternal blood sample obtained from women pregnant with a multiple gestation who were at increased risk for fetal aneuploidy.
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- T21,18 and 13 Screening by Cell Free Fetal DNA in Low Risk Patients#883633
- Health Economic Evaluation of Non-Invasive Prenatal Exclusion Diagnosis#1372898
- Prenatal Analysis of Cell-free Circulating Fetal DNA#1322570
- Non-invasive Prenatal Diagnosis of Monogenic Disorders by Linked-reads Technology#1398027
- A Safer Pre-Natal Diagnosis Using Free DNA in Maternal Blood#1464984
Record · ID 1487171
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive